← Evidence map

ArticleiScience2024

Identification of somatic mutation-driven enhancers and their clinical utility in breast cancer.

Hongying Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38303701